Effect of glutamin on burns

Evaluation the effect of glutamine on inflammation and infectious events in patients with mild burns involving under 20% of the body area

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200929048876N4

Enrollment

Registered

2024-10-10

Start date

2024-10-21

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns involving under 20% of body surface. Burns involving 10-19% of body surface

Interventions

Intervention 1: Intervention group: Glutamin (Karen Company) with the dose of 0.5 g per kilogram body weight in three segmented doses using gavage for one week. Intervention 2: Control group: Corn sta

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Adults hospitalized for minor burns involving less than 20% of the body surface area

Exclusion criteria

Exclusion criteria: Unwillingness to prticipate in the study Intolerance to nutritional support by gavage

Design outcomes

Primary

Measure	Time frame
Bacteriemia. Timepoint: At the baseline and after one week. Method of measurement: Blood culture.;Urinary tract infection. Timepoint: At the baseline and after one week. Method of measurement: Urine culture.;Erythrocyte Sedimentation Rate. Timepoint: At the baseline and after one week. Method of measurement: Blood test.;C-reactive protein. Timepoint: At the baseline and after one week. Method of measurement: Blood test.	—

Measure

Time frame

Bacteriemia. Timepoint: At the baseline and after one week. Method of measurement: Blood culture.;Urinary tract infection. Timepoint: At the baseline and after one week. Method of measurement: Urine culture.;Erythrocyte Sedimentation Rate. Timepoint: At the baseline and after one week. Method of measurement: Blood test.;C-reactive protein. Timepoint: At the baseline and after one week. Method of measurement: Blood test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Seyedeh Neda Mousavi

Zanjan University of Medical Sciences

neda.mousavi@zums.ac.ir+98 24 3377 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026